Exploration of the psychometric properties of the EPDS-US, a validation study.

The purpose of this study was to explore the reliability and construct validity of the EPDS-US. To enhance the perinatal mental health screen, we adapted the Edinburgh Postnatal Depression Screen (EPDS) for application in the United States, and evaluated reliability and construct validity of the EPDS-US in a sample of 100 postpartum individuals. We explored reliability by estimating internal consistency of the scale and evaluating concurrent validity with correlations to the Patient Health Questionnaire (PHQ-9) and the Generalized Anxiety Disorder Assessment (GAD-7); and construct validity using factor analysis and discriminant validity with correlations to the Perceived Stress Scale (PSS). We present both a one-factor (Cronbach's alpha of 0.83) and two-factor model consisting of depressive (Cronbach's alpha 0.76) and anxiety symptoms (Cronbach's alpha 0.78) of the EPDS-US. Related to discriminant validity, the EPDS-US and PSS exhibited a moderate correlation of 0.71. For measures of concurrent validity, correlations with the PHQ-9 and GAD-7 were moderate; 0.63 and 0.68, respectively. The EPDS-US was adapted to enhance the perinatal mental health screening experience for populations in the US while maintaining the reliability and validity of the original Edinburgh Postnatal Depression Scale. These findings contribute to the evidence of reliability and validity of the EPDS-US in perinatal populations in the United States; presenting initial evidence supporting construct validity and concurrent validity of this newly adapted 10-item scale. • The EPDS-US is an adaptioation to enhance the PMH screening experience for populations in the US while maintaining the reliability and validity of the original Edinburgh Postnatal Depression Scale. • This psychometric evaluation of the EPDS-US evaluated construct validity via factor analysis, discriminant validity via correlation with PSS-10 (stress) and concurrent validity via correlations with PHQ-9 (depressive symtpoms) and GAD-7 (anxiety symptoms). • The findings from this study contribute to the evidence of reliability and validity of the EPDS-US in perinatal populations in the US; presenting initial evidence supporting construct validity and concurrent validity of thie newly adapted 10 item scale. [ABSTRACT FROM AUTHOR]